The (pre)hypertension limbo
Is it time to lower the treatment bar?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In 2003, the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) proposed the term “prehypertension” to designate systolic blood pressure (SBP) of 120 to 139 mm Hg and diastolic blood pressure (DBP) of 80–89 mm Hg.1 This classification was based on data that demonstrated a strong, independent, continuous association between blood pressure levels and risk of stroke, ischemic heart disease, and cardiovascular mortality. Above SBP of 115 mm Hg and DBP of 75 mm Hg, this risk doubles with each increment of 20/10 mm Hg.2,3 The term “prehypertension” has been debated contentiously. The 2007 report from the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) preferred to include the 120–129/80–84 mm Hg group with those with “normal blood pressure” and termed the 130–139/85–89 mm Hg group “high normal.”3
The prevalence of prehypertension in the United States is not trivial. About 25% of the adult population is affected (about equal in number to those diagnosed with hypertension).4,5 Approximately 90% of these individuals have at least one other cardiovascular risk factor …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.